Biotest
BIO.F
#4873
Rank
A$2.22 B
Marketcap
$66.71
Share price
-0.49%
Change (1 day)
-5.74%
Change (1 year)

Biotest (BIO.F) - Cash on Hand

Cash on Hand as of June 2024 : A$0.13 Billion

According to Biotest 's latest financial reports the company has A$0.13 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Biotest - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.21 B17.31%
2021-12-31A$0.18 B28.64%
2020-12-31A$0.14 B4.06%
2019-12-31A$0.13 B-20.42%
2018-12-31A$0.17 B297.54%
2017-12-31A$43.34 M-64.17%
2016-12-31A$0.12 B-47.56%
2015-12-31A$0.23 B-33.69%
2014-12-31A$0.34 B9.93%
2013-12-31A$0.31 B334.65%
2012-12-31A$72.8 M-30.91%
2011-12-31A$0.10 B334.02%
2010-12-31A$24.27 M126.19%
2009-12-31A$10.73 M-32.89%
2008-12-31A$15.99 M7.74%
2007-12-31A$14.84 M-0.38%
2006-12-31A$14.9 M21.29%
2005-12-31A$12.28 M-64.31%
2004-12-31A$34.42 M67.74%
2003-12-31A$20.52 M37.03%
2002-12-31A$14.97 M